IL122974A - Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them - Google Patents

Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them

Info

Publication number: IL122974A
Authority: IL; Israel
Prior art keywords: naph; isoquinoline; optionally substituted; pharmaceutical compositions; compositions containing
Prior art date: 1995-08-18

Application number

IL12297496A

Other languages

English (en)

Other versions

IL122974A0 (en

Original Assignee

Purdue Research Foundation

Univ North Carolina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-18

Filing date

1996-08-16

Publication date

2000-11-21

1996-08-16 Application filed by Purdue Research Foundation, Univ North Carolina filed Critical Purdue Research Foundation

1998-08-16 Publication of IL122974A0 publication Critical patent/IL122974A0/xx

2000-11-21 Publication of IL122974A publication Critical patent/IL122974A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 title 2
150000001875 compounds Chemical class 0.000 abstract 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
102000015554 Dopamine receptor Human genes 0.000 abstract 1
108050004812 Dopamine receptor Proteins 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
229960003638 dopamine Drugs 0.000 abstract 1
230000004064 dysfunction Effects 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)

IL12297496A 1995-08-18 1996-08-16 Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them IL122974A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US251995P	1995-08-18	1995-08-18
PCT/US1996/013416 WO1997006799A1 (en)	1995-08-18	1996-08-16	Novel fused isoquinolines as dopamine receptor ligands

Publications (2)

Publication Number	Publication Date
IL122974A0 IL122974A0 (en)	1998-08-16
IL122974A true IL122974A (en)	2000-11-21

Family

ID=21701148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12297496A IL122974A (en)	1995-08-18	1996-08-16	Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them

Country Status (18)

Country	Link
US (2)	US5959110A (de)
EP (1)	EP0845988B1 (de)
JP (1)	JP2000505046A (de)
CN (1)	CN1199338A (de)
AT (1)	ATE209915T1 (de)
AU (1)	AU700688B2 (de)
BR (1)	BR9610323A (de)
CA (1)	CA2227585A1 (de)
DE (1)	DE69617700T2 (de)
DK (1)	DK0845988T3 (de)
ES (1)	ES2169257T3 (de)
IL (1)	IL122974A (de)
MX (1)	MX9801179A (de)
NO (1)	NO308658B1 (de)
NZ (1)	NZ316312A (de)
PT (1)	PT845988E (de)
RU (1)	RU2177001C2 (de)
WO (1)	WO1997006799A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE209915T1 (de) *	1995-08-18	2001-12-15	Purdue Research Foundation	Neue kondensierten isochinoline als dopamin- rezeptor-liganden
EP1320367A4 (de) *	2000-08-11	2007-01-17	Purdue Research Foundation	Verfahren zur herstellung von dinapsolin
US6916823B2 (en) *	2001-01-16	2005-07-12	Purdue Research Foundation	Method of treatment of dopamine-related dysfunction
US7091212B2 (en)	2001-08-10	2006-08-15	Purdue Research Foundation	Chiral dinapsoline
JP2005526728A (ja) *	2002-02-15	2005-09-08	ダーファーマ，インコーポレイテッド	ドーパミンｄ１受容体アゴニストのモノエステルプロドラッグおよび非対称置換ジエステルプロドラッグ
JP2004190007A (ja) *	2002-11-27	2004-07-08	Konica Minolta Holdings Inc	色素およびインクジェット記録液
JP2007506967A (ja) *	2003-09-24	2007-03-22	ビアコーレ・アー・ベー	分子相互作用分析の方法及びシステム
WO2007098462A2 (en) *	2006-02-21	2007-08-30	Purdue Research Foundation	Trans-fused chromenoisoquinolines, synthesis and methods for use
AP2975A (en) *	2008-07-16	2014-09-30	Richter Gedeon Nyrt	Pharmaceutical formulations containing dopamine receptor ligands
US9359303B2 (en)	2009-04-21	2016-06-07	Purdue Research Foundation	Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
CN110068645B (zh) *	2019-04-03	2021-09-03	上海药明奥测医疗科技有限公司	液质联用检测尿液中环磷酸腺苷的方法
KR20220041847A (ko)	2019-07-30	2022-04-01	메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치	섬유성 병리를 치료하기 위한 화합물 및 방법
US20240043396A1 (en) *	2021-01-29	2024-02-08	Mayo Foundation For Medical Education And Research	Methods of treating ocular fibrotic pathologies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4346090A (en) *	1977-07-21	1982-08-24	Ayerst, Mckenna & Harrison Ltd.	13-Chloro-benzocycloheptapyridoisoquinolines and use as neuroleptics
HU180234B (en) *	1979-01-22	1983-02-28	Lilly Co Eli	Process for producing oktahydro-pyrasolo-aracket-3,4-g-bracket closed-quinolines
DE3624607A1 (de) *	1986-07-21	1988-01-28	Boehringer Ingelheim Kg	Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
US5047536A (en) *	1989-03-17	1991-09-10	Purdue Research Foundation	Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) *	1990-09-07	1992-03-11	Abbott Lab	Phenanthridine compounds
CA2054569A1 (en) *	1990-11-07	1992-05-08	Masanobu Suzuki	Process for preparing benzo¬c\|phenanthridinium derivatives, and novel compounds prepared by said process
DE69334206D1 (de) *	1992-05-26	2008-04-03	Purdue Research Foundation	Substituierte hexahydrobenzo(a) phenanthridine
ATE209915T1 (de) *	1995-08-18	2001-12-15	Purdue Research Foundation	Neue kondensierten isochinoline als dopamin- rezeptor-liganden

1996
- 1996-08-16 AT AT96928941T patent/ATE209915T1/de not_active IP Right Cessation
- 1996-08-16 CN CN96197477A patent/CN1199338A/zh active Pending
- 1996-08-16 WO PCT/US1996/013416 patent/WO1997006799A1/en not_active Ceased
- 1996-08-16 AU AU68513/96A patent/AU700688B2/en not_active Ceased
- 1996-08-16 DK DK96928941T patent/DK0845988T3/da active
- 1996-08-16 NZ NZ316312A patent/NZ316312A/xx not_active IP Right Cessation
- 1996-08-16 EP EP96928941A patent/EP0845988B1/de not_active Expired - Lifetime
- 1996-08-16 CA CA002227585A patent/CA2227585A1/en not_active Abandoned
- 1996-08-16 BR BR9610323-0A patent/BR9610323A/pt not_active IP Right Cessation
- 1996-08-16 RU RU98104276/14A patent/RU2177001C2/ru active
- 1996-08-16 PT PT96928941T patent/PT845988E/pt unknown
- 1996-08-16 ES ES96928941T patent/ES2169257T3/es not_active Expired - Lifetime
- 1996-08-16 IL IL12297496A patent/IL122974A/xx not_active IP Right Cessation
- 1996-08-16 DE DE69617700T patent/DE69617700T2/de not_active Expired - Fee Related
- 1996-08-16 MX MX9801179A patent/MX9801179A/es not_active IP Right Cessation
- 1996-08-16 JP JP9509550A patent/JP2000505046A/ja not_active Ceased
- 1996-08-16 US US08/727,451 patent/US5959110A/en not_active Expired - Lifetime
1998
- 1998-02-18 NO NO980688A patent/NO308658B1/no unknown
1999
- 1999-08-13 US US09/374,423 patent/US6194423B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK0845988T3 (da)	2002-04-02
EP0845988A4 (de)	1998-11-11
AU6851396A (en)	1997-03-12
IL122974A0 (en)	1998-08-16
MX9801179A (es)	1998-04-30
NO980688D0 (no)	1998-02-18
PT845988E (pt)	2002-05-31
US6194423B1 (en)	2001-02-27
BR9610323A (pt)	1999-12-21
DE69617700D1 (de)	2002-01-17
CA2227585A1 (en)	1997-02-27
EP0845988B1 (de)	2001-12-05
NO308658B1 (no)	2000-10-09
US5959110A (en)	1999-09-28
JP2000505046A (ja)	2000-04-25
AU700688B2 (en)	1999-01-14
NO980688L (no)	1998-02-18
RU2177001C2 (ru)	2001-12-20
ES2169257T3 (es)	2002-07-01
CN1199338A (zh)	1998-11-18
WO1997006799A1 (en)	1997-02-27
NZ316312A (en)	1999-06-29
ATE209915T1 (de)	2001-12-15
EP0845988A1 (de)	1998-06-10
DE69617700T2 (de)	2002-07-18

Similar Documents

Publication	Publication Date	Title
PL320822A1 (en)	1998-01-05	Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
TW350844B (en)	1999-01-21	Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
IL122974A0 (en)	1998-08-16	Optionally substituted tetrahydro-1H-naph [1, 2, 3-de] isoquinoline and pharmaceutical compositions containing them
HUP9801396A3 (en)	2000-03-28	11-piperidylidene-5h-benzo[5,6]cyclohepta[1,2-b]pirydine-derivatives useful for inhibition of g-protein function and for treatment of proliferative diseases, use thereof and pharmaceutical compositions containing these compounds
IL81234A (en)	1992-09-06	Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
MY121047A (en)	2005-12-30	Bicyclo [2.2.1] heptanes and related compounds
CA2252515A1 (en)	1997-10-30	Pharmaceutical compositions for prevention and treatment of central nervous system disorders
IL112957A0 (en)	1995-06-29	Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
IL114599A0 (en)	1995-11-27	Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
PL330207A1 (en)	1999-04-26	Aryl-substituted cyclic amines as selective ligands of d 3 dopamine
MX9706605A (es)	1998-02-28	Derivados de indol como antagonistas de los aminoacidos exitadores.
GB9212308D0 (en)	1992-07-22	Therapeutic compositions
MX9806171A (es)	1998-10-31	Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
HRP20010969B1 (en)	2005-04-30	Novel piperazinylalkylthiopyrimidine derivatives,
GR3034354T3 (en)	2000-12-29	IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
MX9708557A (es)	1997-12-31	Nuevo uso farmacologico de los antagonistas del receptor aii.
BG101929A (en)	1998-04-30	Benzamides for neurodegenerative disorder treatment
NZ320522A (en)	1999-03-29	Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
UA48962C2 (uk)	2002-09-16	Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
UA41981C2 (uk)	2001-10-15	Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
MXPA98005355A (es)	2004-10-28	Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
MX9703610A (es)	1998-06-30	Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.
PT950053E (pt)	2003-10-31	Novos derivados de benzoilalquil-1,2,3,6-tetra-hidropiridinas
AP9600780A0 (en)	1997-08-05	Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
BG99062A (en)	1995-08-28	POLYMORPH "A" OF N-t-BUTYL-ANDROST-3,5-DIENE-17 -CARBOXAMIDE-3-CARBOXYLIC ACID

Legal Events

Date	Code	Title
2001-04-30	FF	Patent granted
2001-07-24	KB	Patent renewed
2002-11-10	KB	Patent renewed
2006-10-30	KB	Patent renewed
2010-11-30	KB	Patent renewed
2015-03-31	MM9K	Patent not in force due to non-payment of renewal fees